Genetic variants of Anaplasma phagocytophilum from 14 equine granulocytic anaplasmosis cases

doi:10.1186/1756-3305-4-161

Parasit Vectors. 2011; 4: 161.

Published online 2011 August 16. doi: 10.1186/1756-3305-4-161

PMCID: PMC3170280

Genetic variants of Anaplasma phagocytophilum from 14 equine granulocytic anaplasmosis cases

Cornelia Silaghi,¹ Gabriele Liebisch,² and Kurt Pfister¹

¹Comparative Tropical Medicine and Parasitology, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität, Leopoldstr. 5, 80802 Munich, Germany

²Zecklab, Up'n Kampe 3, 30938 Burgwedel, Germany

Corresponding author.

Cornelia Silaghi: cornelia.silaghi/at/tropa.vetmed.uni-muenchen.de; Gabriele Liebisch: liebisch/at/zecklab.de; Kurt Pfister: kurt.pfister/at/tropa.vetmed.uni-muenchen.de

Received April 28, 2011; Accepted August 16, 2011.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

This article has been cited by other articles in PMC.

Abstract

Background

Equine Granulocytic Anaplasmosis (EGA) is caused by Anaplasma phagocytophilum, a tick-transmitted, obligate intracellular bacterium. In Europe, it is transmitted by Ixodes ricinus. A large number of genetic variants of A. phagocytophilum circulate in nature and have been found in ticks and different animals. Attempts have been made to assign certain genetic variants to certain host species or pathologies, but have not been successful so far. The purpose of this study was to investigate the causing agent A. phagocytophilum of 14 cases of EGA in naturally infected horses with molecular methods on the basis of 4 partial genes (16S rRNA, groEL, msp2, and msp4).

Results

All DNA extracts of EDTA-blood samples of the horses gave bands of the correct nucleotide size in all four genotyping PCRs. Sequence analysis revealed 4 different variants in the partial 16S rRNA, groEL gene and msp2 genes, and 3 in the msp4 gene. One 16S rRNA gene variant involved in 11 of the 14 cases was identical to the "prototype" variant causing disease in humans in the amplified part [GenBank: U02521]. Phylogenetic analysis revealed as expected for the groEL gene that sequences from horses clustered separately from roe deer. Sequences of the partial msp2 gene from this study formed a separate cluster from ruminant variants in Europe and from all US variants.

Conclusions

The results show that more than one variant of A. phagocytophilum seems to be involved in EGA in Germany. The comparative genetic analysis of the variants involved points towards different natural cycles in the epidemiology of A. phagocytophilum, possibly involving different reservoir hosts or host adaptation, rather than a strict species separation.

Background

Equine Granulocytic Anaplasmosis (EGA) is caused by Anaplasma phagocytophilum, a tick-transmitted, obligate intracellular bacterium. The vectors are ticks of the genus Ixodes; the main vector in Europe is I. ricinus, in North America I. pacificus and I. scapularis. As no transovarial transmission has been shown, a reservoir animal is necessary for the maintenance in nature [1]. Before 2001, when a reclassification based on 16S rRNA gene similarities was proposed, the causing agent of EGA was known as Ehrlichia equi, which was part of the E. phagocytophila group (including also E. phagocytophila, the causing agent of tick-borne fever of ruminants, and the Human Granulocytic Anaplasmosis (HGA) - agent [2]). Different partial 16S rRNA gene variants of A. phagocytophilum have been detected in previous studies from various host animals and ticks [3-7].

The first case of EGA was reported from northern California in 1969 [8]. Since then reports came from North America and different European countries [9-17]. EGA is an acute febrile disease with an average incubation period of 1-2 weeks. Clinical signs include high fever, depression, anorexia, ataxia, icterus and a lower limb oedema; laboratory findings include thrombocytopenia, anaemia and leucopenia. These abnormalities have been shown both in natural and experimental infections [14,18,19]. The administration of tetracyclines is known as an effective treatment [20], but experimental infection has demonstrated that horses can make a full recovery without treatment [21]. This may account for the relatively high seropositivity as reported in horses in Italy (17.03%) and Denmark (22.3%) [22,23]. No significant difference was found in the seroprevalence between horses with or without suspicion of vector-borne diseases, which suggests the occurrence of subclinical infections [22]. Persistence of A. phagocytophilum was demonstrated in the bloodstream of horses after experimental infection and was not related to clinical disease, raising the question about persistency of a natural infection after an acute outbreak [21]. The existence of persistent infection with a cyclic bacteraemia has also been demonstrated in lambs after experimental infection [24]. The epidemiology of A. phagocytophilum differs between the continents: the outcome of disease in humans is more severe in the US, whereas disease in cattle is virtually non-existent; by contrast, disease is severe in cattle and sheep in Europe, but much rarer and milder in humans [1]. The A. phagocytophilum variant pathogenic for cattle (formerly E. phagocytophila) caused a seroconversion in horses without clinical disease [25]. By contrast, experimental infection with the HGA-agent caused a clinical disease in horses, undistinguishable from EGA [26] and even the death of a horse in another experimental study [27]. Genetic variations have been found previously on basis of the 16S rRNA, groEL, msp2, msp4 and ankA gene in A. phagocytophilum from ticks and animals, however it was not possible to attribute genetic variants to a certain host or geographic origin [3,5-7,28-30]. These investigations showed that A. phagocytophilum seems to show certain genetic heterogeneity; because of this we hypothesised that genetic heterogeneity would also exist in A. phagocytophilum naturally infecting horses and causing EGA. Several steps were taken: from 14 naturally infected horses with clinical EGA, first the 16S rRNA gene was partially amplified and sequenced to gain a general overview of the genetic variety involved. To further analyse the variants involved in equine infections, partial groEL, msp2, and msp4 genes were amplified and sequenced. More than one partial 16S rRNA gene variant was involved in equine infection and genetic variations were also detected in the other amplified parts of genes.

Results

All 14 samples were confirmed positive for A. phagocytophilum by using real-time PCR. The clinical data available for these cases corresponded to the typical clinical signs in EGA [19]. All four genotyping PCRs gave bands of the correct nucleotide size for the partial genes (16S rRNA, groEL, msp2 and msp4). The sequences obtained from this study have been deposited in GenBank [GenBank: JF893886-JF893940, JF907577]. The nucleotide differences are shown in Table Table11.

Table 1

Nucleotide differences of Anaplasma phagocytophilum in the amplified partial genes.

16S rRNA gene sequences

Sequence analysis revealed 4 types in the partial 16S rRNA gene (497 bp; here called "A" (n = 1), "B" (n = 11), "D" (n = 1), "S" (n = 1)). The 16S rRNA gene variant "B" involved in 11 of the 14 cases was identical to the "prototype" variant causing disease in humans in the amplified part [GenBank: U02521]. The partial 16S rRNA gene sequences from this study had 99% to 100% similarity to each other and to the A. phagocytophilum strain HZ [GenBank: NC_007797].

GroEL gene sequences

Four variants were also found in the partial groEL gene (530 bp; here called "a" (n = 1), "b" (n = 11), "r" (n = 1), "l" (n = 1)). The partial groEL gene sequences from this study had 99% to 100% similarity on basis of nucleotides to each other and 98% to 99% to the A. phagocytophilum strain HZ [GenBank: NC_007797]. These nucleotide changes in the partial groEL gene did not result in amino acid changes.

Msp2 gene sequences

The partial msp2 gene revealed also 4 variants (893 bp; here called "I" (n = 4), "II" (n = 7), "III" (n = 2), "IV" (n = 1)). The two main msp2 gene variants "I" and "II" only differed in a single nucleotide polymorphism in the amplified part (nucleotide position 136), which resulted in one amino acid exchange. Msp2 variant "III" had five nucleotide differences from "II" (resulting in one amino acid difference) and 6 nucleotide differences from "I" (resulting in two amino acid differences). Type "IV" had 5 nucleotide differences from "III", 10 nucleotide differences from "II" and 11 nucleotide differences from "I", resulting in 3, 4 and 5 amino acid differences, respectively (Table (Table1).1). On basis of nucleotides, all partial msp2 gene sequences from this study had 98% to 100% similarity amongst each other and 92% to 93% similarity to the A. phagocytophilum strain HZ [NC_007797]. On basis of amino acids, the similarity was 98% to 100% for sequences from this study amongst each other and 87% to 88% to the A. phagocytophilum strain HZ [GenBank: NC_007797].

Msp4 gene sequences

Three variants were detected in the partial msp4 gene (343 bp; here called "c" (n = 11), "s" (n = 1) and "d" (n = 1)). For one sequence only 306 bp could be evaluated. The partial 343 bp msp4 gene sequences from this study had 96% to 100% similarity on basis of nucleotides amongst each other and 96% to 97% to the A. phagocytophilum strain HZ [GenBank: NC_007797]. The nucleotide difference at position 427 in variant "d" resulted in one amino acid exchange (Table (Table11).

For the 11 A. phagocytophilum samples from horses with the 16S rRNA gene variant "B", the msp4 ("variant c") and groEL (variant "b") gene variant were identical, whereas on the basis of the msp2 it was possible to distinguish two different types. The remaining three samples were different from each other in the partial analysed genes and from the other 11 samples (Table (Table22).

Table 2

Details of the horses included in this study and the respective partial genes of Anaplasma phagocytophilum that were detected in them.

Phylogenetic analysis

Phylogenetic analysis of the partial groEL (530 bp), the partial msp2 (893 bp) and the partial msp4 (343 bp) genes was performed with sequences from this study and selected sequences from GenBank (Figure (Figure1).1). As previously shown, the groEL tree clustered into A. phagocytophilum sequences from roe deer and those from other species. The horse sequences clustered within the "other species" group (Figure (Figure1A).1A). Interestingly, one of the partial groEL sequences from horses in this study (variant "a"; GenBank [JF893919]) has been detected previously in roe deer when comparing the amplified 530 bp, according to the GenBank entry [AF478558]. The msp2 phylogenetic tree showed clusters in sequences from US and from Europe; and within these clusters, ruminants clustered separately (Figure (Figure1B).1B). The msp4 phylogenetic tree showed that also US strains clustered separately from the European sequences. The variant "c" clustered separately from the others with a partial msp4 gene previously deposited in GenBank whereas the other two variants "s" and "d" clustered with sequences from ruminant species (Figure (Figure1C1C).

Figure 1

Phylogenetic trees of 530 bp sequences of the groEL (A), 893 bp sequences of the msp2 (B) and 341 bp sequences of the msp4 genes (C). The phylogenetic trees include sequences obtained in this study from Anaplasma phagocytophilum from horses in Germany (more ...)

Discussion

For 14 cases of EGA the causing agent A. phagocytophilum was analysed with molecular methods for variations in four partial genes. Altogether, four different partial 16S rRNA gene variants of A. phagocytophilum were detected to infect horses in Germany. The variant "B" was found identical to the "prototype" variant causing disease in humans in the amplified region [GenBank: U02521] and it was discovered in 11 horses.

This variant has previously been detected in dogs, horses and in roe deer, red deer and sheep [31,32,17,15,7,5]. The 16S rRNA gene variant "B" seems rather rare in ticks in Germany whereas the most frequent variant in ticks seems to be "A" [3, 29, 33, Schorn S. unpublished data]. It was detected in a sample from one horse in this study. 16S rRNA gene type "S" has been detected in sheep, red deer, roe deer, ibex and I. ricinus [7,3,5], whereas type "D" has not been detected yet. Previous studies could not show a host species segregation on basis of the 16S rRNA gene [5,7]. However, by comparing data from our study to GenBank and to previous own investigations [6,7], it became evident that there seem to be 16S rRNA gene variants infecting wild and domestic ruminants (e.g. "X","Y" (Table (Table1),1), as described in [6,7]), and others being the main variants causing disease in humans, horses and dogs (e.g. "B"; [30,32,34]). This could thus indicate potential different natural cycles, even when variants can not be attributed to a particular species. Two variants detected from the clinical EGA cases in this study ("B", "S") seem, however, not confined to domestic animals, but also appear in wild animals which might act as reservoirs (like red deer and roe deer), whereas the possibly "apathogenic" variants ("X", "Y", Table Table1),1), seem to be specific for wild ruminant populations and possibly goats [6,7]. Several questions remain unanswered: may a reservoir animal or a tick form a "bridge" between a potential wild animal and domestic cycle, or could the infection of domestic animals be considered a "spill-over" of variants like "B" and "S"? I. e. are all variants circulating in tick-ruminant cycles, and only a small variety of those cause disease? Horses, dogs and humans have previously been proposed as accidental hosts [35].

The American variant Ap-V1 (matching "X" [6,7] in the amplified part of the 16S rRNA gene), which is supposedly apathogenic, probably has the white-tailed deer as natural reservoir [36]. This variant seems not to cross to dogs, horses and humans either. Two fully different enzootic cycles in nature were suggested for the Western United States as there was no evidence for spatial, genetic or clinical overlap between A. phagocytophilum variants from granulocytic anaplasmosis cases (humans, horses and dogs) and those from the natural wildlife reservoir, the dusky-footed wood rat enzootic cycle [37].

The partial groEL gene variant "b" from this study has previously been detected in horses with EGA in Europe [15,19,38], but horses suffering from EGA from Italy (Sardinia) contained different variants, which were not detected in this study [28]. GroEL-variant "r" has previously been detected from red deer in Slovenia and "l" has been previously detected from an I. ricinus tick in Germany. GroEL-variant "a" has been detected from both dog and roe deer in Slovenia. The clustering of the groEL gene in phylogenetic analysis into a cluster containing sequences from roe deer and another containing sequences derived from other species may show different ancestry for different A. phagocytophilum variants. Some variants may have evolved in a natural cycle adapted to roe deer which may be separate from other variants involving other host species. However, the variant "a" has also been detected from roe deer, which seems to be exceptional when comparing the clustering of this and of previous studies [28]. This observation deserves more attention in future studies on genetic variants of A. phagocytophilum. Whereas the observed nucleotide substitutions in the partial groEL gene did not result in amino acid changes, the variation in the partial major surface protein 2 coding gene did. In the phylogenetic analysis, the partial msp2 gene showed strong clustering between the continents. This may be due to a possible reaction or adaptation to the different vector or host species in the different geographic locations, as it may reflect different host immunity and an adaptation of the pathogen to it [39]. On the other hand, it may be that host specificity or susceptibility are more important than geographic origin. In an experimental study on cross transmission in the US, host susceptibility and transmissibility of A. phagocytophilum may have played a more important role than the vector tick itself [40], which suggests different reservoir host cycles.

The amplification of the partial msp4 gene showed little heterogeneity among horses, both on the nucleotide and at the amino acid level, whereas in large wild animals it showed great heterogeneity, also on amino acid level [7]. In a previous study, the partial msp4 gene variants from ruminants and those from dogs, horses and humans clustered separately [30]. It was suggested that A. phagocytophilum from ruminants may share characteristics, like reservoir and pathogenicity, and that they may be different from the variants found in humans. This strengthens the hypothesis that different enzootic cycles or niches of different variants possibly involving different reservoir hosts exist in nature. A thorough study of the ankA gene from different animal sources came to similar conclusions [5,34]. It was hypothesised that ruminant species can host a larger variety of A. phagocytophilum isolates due to a possible co-evolution of host and pathogen [34]. However, we detected two variants in the partial msp4 gene that clustered within the ruminant cluster. This raises the question whether these two cases in the horses may represent a "spill-over" from ruminant variants, or whether the clustering of the msp4 gene phylogenetic tree may only be weakly supported due to the relatively short sequence used for the comparative analysis. The use of 16S rRNA gene or parts of it as a tool for the molecular characterisation of A. phagocytophilum has been criticized [4,5,32]. Nonetheless the 16S rRNA gene may be very useful, on a broader level, for discriminating variants eliciting granulocytic anaplasmosis from those from a potential wild ruminant cycle. Even though the true genetic variety may be much larger as has been shown e.g. for ankA and msp2 ([3]; results from this study) and a more comprehensive analysis of genetic variants is necessary, the 16S rRNA gene typing seems a good method for initial typing.

Conclusions

We conclude that more than one genetic variant of A. phagocytophilum infects horses and causes EGA in Germany and possibly elsewhere. One main causing variant was 100% similar in the amplified part of the partial 16S rRNA gene to the one pathogenic for humans [GenBank: U02521], but other variants caused clinically apparent infection, too. Comparing this data to sequence data from ticks another type ("A") seems to be the most prevalent one in ticks, but seems to be rather rare in causing disease in horses [[29], Schorn et al., unpublished data]. This gives a strong basis for hypothesising that A. phagocytophilum may exist in different natural cycles involving different reservoir hosts. This tendency has also been shown in previous studies [5,30]. We further conclude that for a preliminary comparative typing of A. phagocytophilum the partial 16S rRNA gene seems a useful tool. Therefore, even when other genes are studied for phylogenetic or other differentiation or in the search for better markers for typing, 16S rRNA variant typing should also be performed.

Methods

Horses and clinical assessment

Fourteen cases of clinical EGA, diagnosed from 2004 to 2009, were included in this study (Table (Table2).2). The horses were from three federal states of Germany: Lower Saxony (n = 6), North-Rhine Westphalia (n = 6) and Bavaria (n = 2) (Figure (Figure2).2). The diagnosis which had been requested by the veterinarians for routine diagnostics at the time of infection had been taken with Giemsa stained buffy coat smears. In all 14 horses, morulae had been detected in the granulocytes. For 3 horses, diagnosis at the time had also been taken by PCR. EDTA-blood which was left over from the routine diagnosis of the horses was preserved at -20°C for further use in this study. All 14 animals were suffering from high fever, 8 of them recurring, 5 horses had icterus, 2 a lower limb oedema, and further 2 anorexia. 13 animals showed thrombocytopenia, 6 monocytopenia, and 5 lymphopenia, the total bilirubin was increased for 5 horses. 7 horses were previously treated with penicillin or other antibiotics not acting against A. phagocytophilum.

Figure 2

Map of Germany showing the origin of the horses included in this study. The location where the horses were staying at the time of diagnosis is shown according to the postal code in the respective districts (shaded in red) within the federal states. The (more ...)

DNA-Extraction and Polymerase Chain Reaction

DNA was extracted with the HighPure PCR Template Preparation Kit (Roche, Mannheim, Germany). The presence of specific A. phagocytophilum DNA was verified in all samples with a real-time PCR targeting the msp2 gene as previously described ([41,6]). The conditions and primers for sequence analysis of the partial 16S rRNA, groEL, msp2, and msp4 genes are listed in Table Table3.3. The PCRs were carried out on the thermocyclers GeneAmp System 2700/Veriti (Applied Biosystems, Weiterstadt, Germany) or an Eppendorf Mastercycler gradient (Eppendorf, Hamburg, Germany). The HotStarTaq Kit (Qiagen, Hilden, Germany) was used for all PCR experiments. Positive (DNA of A. phagocytophilum infected I. ricinus ticks) and negative (molecular biology grade water) controls were included in each PCR run. Successful amplification of the gene targets was verified with 2.0% agarose gel-electrophoresis after staining with GelRed^®(Biotium, Hayward, USA) and visualized under UV-light.

Table 3

Primers used for the PCRs for sequence analysis for Anaplasma phagocytophilum from horses in this study.

Sequence Analysis

PCR products were purified with the QIAquick PCR Purification Kit according to manufacturer's instruction (Qiagen, Hilden, Germany) and sent for sequencing with forward and reverse primers (Table (Table3)3) to Eurofins MWG Operon (Martinsried, Germany). The obtained chromatograms were evaluated with Chromas^©Lite http://www.technelysium.com.au/chromas_lite.html. ClustalW2 was used to perform multiple sequence alignment of the sequences [45]. Nucleotide sequences were translated to amino acid level using Transeq http://www.ebi.ac.uk/emboss/transeq/. Sequence homology searches were made by BLASTn analysis of GenBank http://www.ncbi.nlm.nih.gov.library.vu.edu.au/BLAST/.

Phylogenetic analysis

Phylogenetic analysis was carried out with the PHYLIP 3.67 software package [46] using the neighbor joining method. For this analysis 33 sequences of the partial groEL gene, 16 of the partial msp2 gene and 22 of the partial msp4 gene were used from GenBank. Distance matrices were calculated with the Kimura 2-parameter method using DNADIST. A bootstrap analysis was performed to test the stability of the trees with 1000 resamplings using SEQBOOT. Consensus trees were derived with CONSENSE.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CS organised and established the laboratory work, carried out the sequence and phylogenetic analysis and wrote the manuscript. GL provided the samples and clinical data for this study, and GL and KP critically revised the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors thank Sina Thienel and Claudia Thiel for technical assistance in the laboratory.

References

Woldehiwet Z. Anaplasma phagocytophilum in ruminants in Europe. Ann N Y Acad Sci. 2006;1078:446–460. doi: 10.1196/annals.1374.084. [PubMed] [Cross Ref]
Dumler JS, Barbet AF, Bekker CP, Dasch GA, Palmer GH, Ray SC, Rikihisa Y, Rurangirwa FR. Reorganization of the genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia, and Ehrlichia with Neorickettsia, descriptions and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol. 2001;51:2145–2165. doi: 10.1099/00207713-51-6-2145. [PubMed] [Cross Ref]
Von Loewenich FD, Baumgarten BU, Schröppel K, Geißdörfer W, Röllinghoff M, Bogdan C. High Diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. J Clin Microbiol. 2003;41:2033–5040. doi: 10.1128/JCM.41.5.2033-2039.2003. [PMC free article] [PubMed] [Cross Ref]
Zeman P, Pecha M. Segregation of genetic variants of Anaplasma phagocytophilum circulating among wild ruminants within a Bohemian forest (Czech Republic) Int J Med Microbiol. 2008;298(Suppl 1):203–210.
Scharf W, Schauer S, Freyburger F, Petrovec M, Schaarschmidt-Kiener D, Liebisch G, Runge M, Ganter M, Kehl A, Dumler JS, Garcia-Perez AL, Jensen J, Fingerle V, Meli ML, Ensser A, Stuen S, von Loewenich FD. Distinct host species correlate with Anaplasma phagocytophilum ankA gene clusters. J Clin Microbiol. 2011;49:790–796. doi: 10.1128/JCM.02051-10. [PMC free article] [PubMed] [Cross Ref]
Silaghi C, Scheuerle MC, Friche Passos LM, Thiel C, Pfister K. PCR detection of Anaplasma phagocytophilum in goat flocks in an area endemic for tick-borne fever in Switzerland. Parasite. 2011;18:57–62. [PubMed]
Silaghi C, Hamel D, Thiel C, Pfister K, Friche Passos LM, Rehbein S. Genetic variants of Anaplasma phagocytophilum in wild caprine and cervid ungulates from the Alps in Tyrol, Austria. Vector Borne Zoonotic Dis. 2011. in press . [PubMed]
Gribble DH. Equine ehrlichiosis. J Am Vet Med Assoc. 1969;155:462–469. [PubMed]
Büscher G, Gandras R, Apel G, Friedhoff KT. [The 1st case of ehrlichiosis in a horse in Germany (Brief report)] Dtsch Tierarztl Wochenschr. 1984;91:408–409. [PubMed]
Hermann M, Baumann D, Lutz H, Wild P. Erster diagnostizierter Fall von Equiner Ehrlichiose in der Schweiz. Pferdeheilkunde. 1985;1:247–250.
Bjoersdorff A. Ehrlichia equi infection diagnosed in horses. Svensk Veterinär Tidning. 1990;42:357–360.
Korbutiak E, Schneiders D. Equine Granulocytic Ehrlichiosis in the UK. Vet Rec. 1994;135:387–388. [PubMed]
Berrington A, Moats R, Lester S. A case of Ehrlichia equi in an adult horse in British Columbia. Can Vet. 1996;37:174–175. [PMC free article] [PubMed]
Bermann F, Davoust B, Fournier PE, Brisou-Lapointe AV, Brouqui P. Ehrlichia equi (Anaplasma phagocytophila) infection in an adult horse in France. Vet Rec. 2002;150:787–788. doi: 10.1136/vr.150.25.787. [PubMed] [Cross Ref]
Von Loewenich FD, Stumpf G, Baumgarten BU, Röllinghoff M, Dumler JS, Bogdan C. A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic Anaplasma phagocytophilum (HGE agent) in Germany. Eur J Clin Microbiol Infect Dis. 2003;22:303–305. [PubMed]
Butler CM, Nijhof AM, Jongejan F, Van der Kolk JH. Anaplasma phagocytophilum infection in horses in the Netherlands. Vet Rec. 2008;162:216–218. doi: 10.1136/vr.162.7.216. [PubMed] [Cross Ref]
Jahn P, Zeman P, Bezdekova B, Praskova I. Equine granulocytic anaplasmosis in the Czech Republic. Vet Rec. 2010;166:646–649. doi: 10.1136/vr.4852. [PubMed] [Cross Ref]
Reubel GH, Kimsey RB, Barlough JE, Madigan JE. Experimental transmission of Ehrlichia equi to horses through naturally infected ticks (Ixodes pacificus) from Northern California. J Clin Microbiol. 1998;38:2131–2134. [PMC free article] [PubMed]
Franzén P, Aspan A, Egenvall A, Gunnarsson A, Åberg L, Pringle J. Acute Clinical, Hematologic, Serologic, and Polymerase Chain Reaction findings in horses experimentally infected with a European strain of Anaplasma phagocytophilum. J Vet Intern Med. 2005;19:232–239. [PubMed]
Madigan JE. Equine Ehrlichiosis. Vet Clin North Am Equine Pract. 1993;9:423–428. [PubMed]
Franzén P, Aspan A, Egenvall A, Gunnarsson A, Karlstam E, Pringle J. Molecular evidence for persistence of Anaplasma phagocytophilum in the absence of clinical abnormalities in horses after recovery from acute experimental infection. J Vet Intern Med. 2009;23:636–642. doi: 10.1111/j.1939-1676.2009.0317.x. [PubMed] [Cross Ref]
Passamonti F, Veronesi F, Cappelli K, Capomaccio S, Coppola G, Marenzoni ML, Piergili FD, Verini Supplizi A, Coletti M. Anaplasma phagocytophilum in horses and ticks: A preliminary survey of Central Italy. Comp Immunol Microbiol Infect Dis. 2010;33:73–83. doi: 10.1016/j.cimid.2008.08.002. [PubMed] [Cross Ref]
Hansen MGB, Christoffersen M, Thuesen LR, Petersen MR, Bojesen AM. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in Danish horses. Act Vet Scand. 2010;52:3. doi: 10.1186/1751-0147-52-3. [PMC free article] [PubMed] [Cross Ref]
Granquist EG, Bårdsen K, Bergström K, Stuen S. Variant - and individual dependent nature of persistent Anaplasma phagocytophilum infection. Acta Vet Scand. 2010;52:25. doi: 10.1186/1751-0147-52-25. [PMC free article] [PubMed] [Cross Ref]
Pusterla N, Lutz H, Braun U. Experimental infection of four horses with Ehrlichia phagocytophila. Vet Rec. 1998;143:303–305. doi: 10.1136/vr.143.11.303. [PubMed] [Cross Ref]
Barlough JE, Madigan JE, DeRock E, Dumler JS, Bakken JS. Protection against Ehrlichia equi is conferred by prior infection with the Human Granulocytotropic Ehrlichia (HGE Agent) J Clin Microbiol. 1995;33:3333–3334. [PMC free article] [PubMed]
Franzén P, Berg A-L, Aspan A, Gunnarson A, Pringle J. Death of a horse infected experimentally with Anaplasma phagocytophilum. Vet Rec. 2007;160:122–125. doi: 10.1136/vr.160.4.122. [PubMed] [Cross Ref]
Alberti A, Zobba R, Chessa B, Addis MF, Sparagano O, Parpaglia MLP, Cupeddu T, Pintori G, Pittau M. Equine and Canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States. Appl Env Microbiol. 2005;71:6418–6422. doi: 10.1128/AEM.71.10.6418-6422.2005. [PMC free article] [PubMed] [Cross Ref]
Silaghi C, Gilles J, Höhle M, Fingerle V, Just FT, Pfister K. Anaplasma phagocytophilum infection in Ixodes ricinus, Bavaria, Germany. Emerg Infect Dis. 2008;14:972–974. doi: 10.3201/eid1406.071095. [PMC free article] [PubMed] [Cross Ref]
De la Fuente J, Massung RF, Wong SJ, Chu FK, Lutz H, Meli M, von Loewenich FD, Grzeszczuk A, Torina A, Caracappa S, Mangold AJ, Naranjo V, Stuen S, Kocan KM. Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains. J Clin Microbiol. 2005;43:1309–1317. doi: 10.1128/JCM.43.3.1309-1317.2005. [PMC free article] [PubMed] [Cross Ref]
Johansson K-E, Pettersson B, Uhlén M, Gunnarsson A, Malmquist M, Olsson E. Identification of the causative agent of granulocytic ehrlichiosis in Swedish dogs and horses by direct solid phase sequencing of PCR products from the 16S rRNA gene. Res Vet Sci. 1995;58:109–112. doi: 10.1016/0034-5288(95)90061-6. [PubMed] [Cross Ref]
Zeman P, Jahn P. An entropy-optimized multilocus approach for characterizing the strains of Anaplasma phagocytophilum infecting horses in the Czech Republic. J Med Microbiol. 2009;58:423–429. doi: 10.1099/jmm.0.007831-0. [PubMed] [Cross Ref]
Leonard S. Doctoral Thesis. Ludwig-Maxmilians-Universtät München, Institute of Comparative Tropical Medicine and Parasitology; 2005. Untersuchung zur Häufigkeit von Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum und Babesia spp. in Ixodes ricinus aus Bayern und Baden-Württemberg.
Schauer S. Doctoral Thesis. Albert-Ludwigs-Universität Freiburg im Breisgau, Institute for Medical Microbiology and Hygiene; 2008. Genetische Charakterisierung von Anaplasma phagocytophilum Stämmen.
Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet Res. 2005;36:469–92. doi: 10.1051/vetres:2005004. [PubMed] [Cross Ref]
Massung RF, Courtney JW, Hiratzka SL, Pitzer VE, Smith G, Dryden RL. Anaplasma phagocytophilum in white-tailed deer. Emerg Infect Dis. 2005;11:1604–6. [PMC free article] [PubMed]
Foley J, Nieto NC, Madigan J, Sykes J. Possible differential host tropism in Anaplasma phagocytophilum strains in the Western United States. Ann N Y Acad Sci. 2008;1149:94–97. doi: 10.1196/annals.1428.066. [PubMed] [Cross Ref]
Pusterla N, Huder JB, Feige K, Lutz H. Identification of a Granulocytic Ehrlichia Strain isolated from a horse in Switzerland and comparison with other rickettsiae of the Ehrlichia phagocytophila genogroup. J Clin Microbiol. 1998;36:2035–2037. [PMC free article] [PubMed]
Granquist EG, Stuen S, Lundgren AM, Braten M, Barbet AF. Outer Membrane Protein sequence variation in lambs experimentally infected with Anaplasma phagocytophilum. Infect Immun. 2008;76:120–126. doi: 10.1128/IAI.01206-07. [PMC free article] [PubMed] [Cross Ref]
Teglas MB, Foley J. Differences in the transmissibility of two Anaplasma phagocytophilum strains by the North American tick vector species, Ixodes pacificus and Ixodes scapularis (Acari: Ixodidae) Exp Appl Acarol. 2006;38:47–58. doi: 10.1007/s10493-005-5293-5. [PubMed] [Cross Ref]
Courtney JW, Kostelnik LM, Nordin SZ, Massung RF. Multiplex Real-Time PCR for detection of Anaplasma phagocytophilum and Borrelia burgdorferi. J Clin Microbiol. 2004;42:3164–3168. doi: 10.1128/JCM.42.7.3164-3168.2004. [PMC free article] [PubMed] [Cross Ref]
Massung RF, Slater K, Owens JH, Nicholson WL, Mather TN, Solberg VB, Olson JG. Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol. 1998;36:1090–1095. [PMC free article] [PubMed]
Lin Q, Rikihisa Y, Massung RF, Woldehiwet Z, Falco RC. Polymorphism and Transcription at the p44-1/p44-18 Genomic Locus in Anaplasma phagocytophilum Strains from Diverse Geographic Regions. Infect Immun. 2004;72:5574–5581. doi: 10.1128/IAI.72.10.5574-5581.2004. [PMC free article] [PubMed] [Cross Ref]
Bown KJ, Lambin X, Ogden NH, Petrovec M, Shaw SE, Woldehiwet Z, Birtles RJ. High-resolution genetic fingerprinting of European strains of Anaplasma phagocytophilum by use of multilocus variable-number tandem-repeat analysis. J Clin Microbiol. 2007;45:1771–1776. doi: 10.1128/JCM.00365-07. [PMC free article] [PubMed] [Cross Ref]
Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003;31:3497–500. doi: 10.1093/nar/gkg500. [PMC free article] [PubMed] [Cross Ref]
Felsenstein J. PHYLIP - phylogeny interference package (version 3.2) Cladistics. 1989;5:164–166.

Articles from Parasites & Vectors are provided here courtesy of
BioMed Central